1273 Effect of systemic immunosuppression timing on overall survival among immune checkpoint inhibitor recipients

• Kun-Hsing Yu,
• Shijia Zhang,
• Nga Nguyen,
• Feng Liu,
• Nikolai Klebanov,
• Alexander Gusev,
• Shawn Kwatra,
• Yevgeniy R Semenov,
• Genevieve M Boland,
• Nicole R LeBoeuf,
• Kimberly Tang,
• Guihong Wan,
• Boshen Yan,
• Munachimso Amadife,
• Bonnie W Leung

Affiliations

Kun-Hsing Yu

2Harvard Medical School, Boston, MA, USA

Shijia Zhang

Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA

Nga Nguyen

Department of Health Education, Faculty of Social Science, Behavior and Health Education, Hanoi University of Public Health, Hanoi, Vietnam

Feng Liu

Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, People`s Republic of China

Nikolai Klebanov

2Massachusetts General Hospital, Boston, MA, USA

Alexander Gusev

Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Shawn Kwatra

5Johns Hopkins University, Baltimore, MD, USA

Yevgeniy R Semenov

1Massachusetts General Hospital, Boston, MA, USA

Genevieve M Boland

Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Nicole R LeBoeuf

2Dana Farber Cancer Institute, Boston, MA, USA

Kimberly Tang

2Massachusetts General Hospital, Boston, MA, United States

Guihong Wan

1Massachusetts General Hospital, Boston, MA, USA

Boshen Yan

1Massachusetts General Hospital, Boston, MA, USA

Munachimso Amadife

1Massachusetts General Hospital, Boston, MA, USA

Bonnie W Leung

1Massachusetts General Hospital, Boston, MA, USA